ESC: European Society of Cardiology – Page 4 – MDConnect

CMR fast-SENC segmental intramyocardial LV strain monitors decline in heart function before ejection fraction in patient with arterial hypertension

This paper was presented on Saturday 29th August 2020 at the ESC Congress 2020 – The Digital Experience by Dr

July 6, 2021

High prevalence of familial and genetic disease in children with cardiomyopathies: Baseline paediatric data from the ESC EORP Cardiomyopathy and Myocarditis Registry

This paper was presented on Saturday 29th August 2020 at the ESC Congress 2020 – The Digital Experience by Dr

July 5, 2021

Atrial strain in cardiac ATTR amyloidosis from pathophysiology to prognosis: is it time to rethink our approach to disease?

This paper was presented on Saturday 29th August 2020 at the ESC Congress 2020 – The Digital Experience by Dr

June 28, 2021

Long-term outcomes in newly diagnosed pulmonary arterial hypertension ( PAH ) patients receiving initial triple oral combination therapy: Insights from the randomized controlled TRITON study

This Hot Line Study was presented on Saturday 29th August 2020 at the ESC Congress 2020 – The Digital Experience

June 24, 2021

Fibromuscular dysplasia – An often undetected condition

This Study was presented on Saturday 29th August 2020 at the ESC Congress 2020 – The Digital Experience by Dr

June 24, 2021

Clinical practice update on blood pressure measurement in atrial fibrillation

This Study was presented on Saturday 29th August 2020 at the ESC Congress 2020- The Digital Experience by Dr Georgios

June 24, 2021

Early intervention improves outcomes in patients with newly diagnosed atrial fibrillation – results from the EAST-AFNET 4 trial

This Hot Line Study was presented on Saturday 29th August 2020 at the ESC Congress 2020 – The Digital Experience.

June 23, 2021

Lowering triglycerides with antisense oligonucleotides – are we making progress?

This Late Breaking Science study was presented on Saturday 29th August 2020 at the ESC Congress 2020- The Digital Experience.

June 23, 2021

Not just in diabetes empagliflozin improves outcomes in patients with heart failure in the EMPEROR-Reduced trial

This Hot line study was presented on Saturday 29th August 2020 at the ESC Congress2020 – The Digital Experience. Sodium-glucose

June 22, 2021

Bringing hope to patients with obstructive hypertrophic cardiomyopathy – results from the EXPLORER – HCM trial

This Hot line study was presented on Saturday 29th August 2020 at the ESC Congress 2020- The Digital Experience. Mavacamten

June 22, 2021